MedPath

PRZ-SOLIFENACIN

PRZ-SOLIFENACIN

Approved
DIN Number

02493047

Drug Class

Human

Market Date

Nov 13, 2020

Company
HC

pharmaris canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02493047
AIG Number0151584002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G04BD08 SOLIFENACIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification86:12.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

SOLIFENACIN SUCCINATEActive
Strength: 10 MG
Monograph: SOLIFENACIN SUCCINATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.